Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Cervantes F, Ross DM, Radinoff A, Palandri F, et al. Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study. Leukemia 2021 May 20. pii: 10.1038/s41375-021-01261.
PMID: 34017073


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016